Shares of medical device company Motus GI Holdings fell about 8% in their trading debut Wednesday, after the company priced its initial public offering at the low end of its $5 to $7 range. The Israeli company sold 3.5 million shares to raise $18.5 million. The company was originally planning to offer 4.3 million shares but reduced the size of the deal ahead of pricing. Few companies have braved the IPO market this week, given the recent volatility and a traditional seasonal lull as financials are updated. Motus was down 39 cents at $4.61 midmorning, trading on Nasdaq under the ticker symbol “MOTS.” Piper Jaffray and Oppenheimer were joint bookrunners on the deal. The S&P 500 was up 0.4%.
Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.
From:: Stock Market News